Literature DB >> 29803922

MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.

Wen Zhao1, Qiang Sun2, Zepeng Yu3, Shuai Mao4, Yingkang Jin1, Jiajun Li3, Zhiyi Jiang3, Yongqiang Zhang3, Mian Chen3, Peiran Chen3, Dongdong Chen3, Hailin Xu3, Shangwei Ding5, Zhiqi Yu6.   

Abstract

MicroRNAs (miRNAs) play important roles in tumorigenesis and tumor progression. In this study, we investigated the role of miR-320a-3p in non-small cell lung cancer (NSCLC). Expressions of miR-320a-3p were firstly determined in 80 NSCLC patients' cancer tissues and adjacent normal lung tissues by qRT-PCR. Then MTT assay, cell migration and invasion assays were performed in vitro. Potential binding sites on target gene of miR-320a-3p were predicted and luciferase reporter assay was used to identify the potential binding sites. Tumorigenesis assay were performed in nude mice by injecting A549 cells which stably express miR-320a-3p. Results indicated that high expression of miR-320a-3p suppresses cell proliferation, migration and invasion through the inactivation of PI3K/Akt signaling pathway in NSCLC cells. Smaller tumor size and lighter weight were also found in nude mice which had miR-320a-3p higher expressed. Furthermore, data from luciferase reporter assay proved the direct binding of miR-320a-3p on the 3'UTR region of ELF3 mRNA, this could further decrease ELF3 expression transcriptionally. We provided evidence that miR-320a-3p might work as a tumor suppressor in NSCLC both in vivo and in vitro.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ELF3; NSCLC; PI3K/Akt; miR-320a-3p

Mesh:

Substances:

Year:  2018        PMID: 29803922     DOI: 10.1016/j.gene.2018.05.100

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

1.  LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1.

Authors:  Shuaihao Huang; Xiaowen Zhu; Yuhong Ke; Dan Xiao; Changxiang Liang; Junfeng Chen; Yunbing Chang
Journal:  Cancer Biol Ther       Date:  2020-01-10       Impact factor: 4.742

2.  Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis.

Authors:  Lu Zhang; Huihui Li; Ming Yuan; Dong Li; Chang Sun; Guoyun Wang
Journal:  Dis Markers       Date:  2020-01-23       Impact factor: 3.434

3.  High-quality human preimplantation embryos stimulate endometrial stromal cell migration via secretion of microRNA hsa-miR-320a.

Authors:  Robbert P Berkhout; Remco Keijser; Sjoerd Repping; Cornelis B Lambalk; Gijs B Afink; Sebastiaan Mastenbroek; Geert Hamer
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

4.  miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1.

Authors:  Lei Wu; Tianyi Wang; Dongning He; Xiaoxi Li; Youhong Jiang
Journal:  Onco Targets Ther       Date:  2018-12-06       Impact factor: 4.147

Review 5.  miR-181a/b therapy in lung cancer: reality or myth?

Authors:  Cornelia Braicu; Diana Gulei; Roxana Cojocneanu; Lajos Raduly; Ancuta Jurj; Erik Knutsen; George Adrian Calin; Ioana Berindan-Neagoe
Journal:  Mol Oncol       Date:  2019-01-03       Impact factor: 6.603

Review 6.  MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Authors:  Yuanyuan Liang; Shun Li; Liling Tang
Journal:  Biomedicines       Date:  2021-05-23

7.  P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Authors:  Caterina Costa; Paola Indovina; Eliseo Mattioli; Iris Maria Forte; Carmelina Antonella Iannuzzi; Luca Luzzi; Cristiana Bellan; Simona De Summa; Enrico Bucci; Domenico Di Marzo; Marisa De Feo; Luciano Mutti; Francesca Pentimalli; Antonio Giordano
Journal:  Cell Death Dis       Date:  2020-09-14       Impact factor: 8.469

8.  Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.

Authors:  Songlin Li; Yuan Yuan; He Xiao; Jiajia Dai; Yunfei Ye; Qin Zhang; Zhimin Zhang; Yuhan Jiang; Jia Luo; Jing Hu; Chuan Chen; Ge Wang
Journal:  Clin Epigenetics       Date:  2019-03-04       Impact factor: 6.551

9.  The Metastasis Potential Promoting Capacity of Cancer-Associated Fibroblasts Was Attenuated by Cisplatin via Modulating KRT8.

Authors:  Xueqin Li; Qianqian Song; Xueru Guo; Limin Wang; Qicheng Zhang; Limin Cao; Yinghui Ren; Xiang Wu; Zhaowei Meng; Ke Xu
Journal:  Onco Targets Ther       Date:  2020-04-01       Impact factor: 4.147

10.  eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition.

Authors:  Han-Han Zhang; Ran Li; You-Jie Li; Xin-Xin Yu; Qian-Nan Sun; Ao-Ying Li; Ying Kong
Journal:  Oncol Rep       Date:  2019-12-16       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.